Skip to main content Accessibility help
×
Home
  • Print publication year: 2018
  • Online publication date: May 2018

Chapter 13 - Management of Psychiatric Issues in Epilepsy

Related content

Powered by UNSILO
Barry, J. J., Ettinger, A. B., Friel, P., et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008;13(Suppl 1): S1–29.
Caplan, R., Siddarth, P., Gurbani, S., et al. Depression and anxiety disorders in pediatric epilepsy. Epilepsia 2005;46: 720–30.
FDA. Information for Healthcare Professionals: Suicidal Behavior and Ideation and Antiepileptic Drugs. www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100192.htm.
Fiest, K. M., Patten, S. B. Screening for depression and anxiety in epilepsy. Neurol Clin 2016;34: 351–61.
Gilliam, F. G., Barry, J. J., Meador, K. J., et al. Rapid detection of major depression in epilepsy: a multicenter study. Lancet Neurol 2006;5(5): 399405.
Harden, C. L., Goldstein, M. A., Ettinger, A. B. Anxiety disorders in epilepsy. In: Ettinger, A. B., Kanner, A. M., eds. Psychiatric issues in epilepsy: a practical guide to diagnosis and treatment, 2nd edn. Philadelphia, PA: Lippincott Williams & Wilkins; 2006, 248–63.
Jones, J. E., Hermann, B. P., Barry, J. J., et al. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003;4(Suppl 3): S31–8.
Kanner, A. M., Kozak, A. M., Frey, M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav 2000;1(2): 100–5.
Kanner, A. M., Schachter, S. C., Barry, J. J., et al. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav 2012;24: 156–68.
Kimiskidis, V. K., Triantafyllou, N. I., Kararizou, E., et al. Depression and anxiety in epilepsy: the association with demographic and seizure-related variables. Ann Gen Psychiatry, 2007;6: 28.
Leeman-Markowski, B. A., Schachter, S. C. Psychiatric comorbidity of epilepsy. In: Wyllie, E., Gidal, B., Goodkin, H., Loddenkemper, T., Sirven, J., eds. Wyllie's treatment of epilepsy, 6th edn. Philadelphia: Wolters Kluwer; 2015, 995–1010.
Nilsson, L., Ahlbom, A., Farahmand, B. Y., et al. Risk factors for suicide in epilepsy: a case control study. Epilepsia 2002;43: 644–51.
Trimble, M. R., Mula, M. Antiepileptic drug interactions in patients requiring psychiatric drug treatment. In: Antiepileptic drugs. Combination therapy and interactions. Majkowski, J., Bourgeois, B., Patsalos, P., Mattson, R., eds. Cambridge: Cambridge University Press; 2005, 350–68.
Walker, E. R., Obolensky, N., Dini, S., Thompson, N. J. Formative and process evaluations of a cognitive-behavioral therapy and mindfulness intervention for people with epilepsy and depression. Epilepsy Behav 2010;19: 239–46.